Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Nov;35(11):1020-6.
doi: 10.1111/j.1600-0560.2007.00954.x. Epub 2008 Jun 4.

Superficial acral fibromyxoma: a clinicopathological analysis of 32 tumors including 4 in the heel

Affiliations

Superficial acral fibromyxoma: a clinicopathological analysis of 32 tumors including 4 in the heel

Wael I Al-Daraji et al. J Cutan Pathol. 2008 Nov.

Abstract

Aims: To examine a series of superficial acral fibromyxomas (SAFs) and discuss our experience with this new entity and its differential diagnosis in the past 5 years.

Methods and results: Thirty-two new cases of SAF were studied between 2001 and 2006. The patients included 22 males and 10 females with an age range between 23 and 82 years (mean 51, median 53) presenting with a solitary mass or nodule with an average size of 2 cm. The sites were the toes (n = 15) and fingers (n = 13) with 66.6% of tumors close to or involving the nail bed. Four tumors occurred in the heel where SAF has not been previously observed. Local recurrences developed in 3 of 14 patients (22%). Histologically, all tumors presented with spindle cells with a vague storiform and fascicular pattern embedded in a myxoid/fibromyxoid/collagenous stroma. A characteristic immunophenotype included CD34+, CD99+/- and EMA+ focally. One case showed moderate cytological atypia with 1 mitosis per 10 HPF, but a 4-year follow up showed no evidence of recurrence.

Conclusion: Thirty-two new cases of SAF confirm this tumor as a reproducible entity. Occurrence in the heel, a new site for this tumor, was reported in four cases. Recurrence rate of this tumor may exceed 20%.

PubMed Disclaimer

Comment in

  • When a negative is a positive!
    Mahalingam M. Mahalingam M. J Cutan Pathol. 2009 Sep;36(9):1022-3. doi: 10.1111/j.1600-0560.2009.01193.x. J Cutan Pathol. 2009. PMID: 19674207 No abstract available.

MeSH terms

LinkOut - more resources